1.
Darmon P, Castera V, Koeppel MC, Petitjean C, Dutour A. Type III allergy to insulin detemir. Diabetes Care. 2005;28(12):2980.
CrossRefPubMed
2.
Marusic S, Vlahovic-Palcevski V, Ljubanovic D. Leukocytoclastic vasculitis associated with insulin aspart in a patient with type 2 diabetes. Int J Clin Pharmacol Ther. 2009;47(10):603–605.
CrossRefPubMed
3.
Rachid B, Rabelo-Santos M, Mansour E, de Lima Zollner R, Velloso LA. Type III hypersensitivity to insulin leading to leukocytoclastic vasculitis. Diabetes Res Clin Pract. 2010;89(3):e39–40.
4.
Mandrup-Poulsen T, Mølvig J, Pildal J, et al. Leukocytoclastic vasculitis induced by subcutaneous injection of human insulin in a patient with type I diabetes and essential thrombocytemia. Diabetes Care. 2002;25(1):242–243.
5.
Silva ME, Mendes MJ, Ursich MJ, et al. Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient. Diabetes Res Clin Pract. 1997;36(2):67–70.
6.
Paley R, Tunbridge R. Dermal reactions to insulin therapy. Diabetes. 1952;1(1):22–27.
7.
Arkins JA, Engbring NH, Lennon EJ. The incidence of skin reactivity to insulin in diabetic patients. J Allergy. 1962;33:69–72.
8.
Radermecker RP, Scheen AJ. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev. 2007;23(5):348–355.
9.
Ghazavi MK, Johnston GA. Insulin allergy. Clin Dermatol. 2011;29(3):300–305.
10.
Mattson JR, Patterson R, Roberts M. Insulin therapy in patients with systemic insulin allergy. Arch Intern Med. 1975;135(6):818–821.
11.
deShazo RD, Boehm TM, Kumar D, et al. Dermal hypersensitivity reactions to insulin: correlations of three patterns to their histopathology. J Allergy Clin Immunol. 1982;69(2):229–237.
12.
Pratt EJ, Miles P, Kerr D. Localized insulin allergy treated with continuous subcutaneous insulin. Diabet Med. 2001;18(6):515–516.
13.
Moyes V, Driver R, Croom A, Mirakian R, Chowdhury TA. Insulin allergy in a patient with type 2 diabetes successfully treated with subcutaneous insulin infusion. Diabet Med. 2006;23(2):204–206.
14.
Grant W, deShazo RD, Frentz J. Use of low-dose continuous corticosteroid infusion to facilitate insulin pump use in local insulin hypersensitivity. Diabetes Care. 1986;9(3):318–319.
15.
Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care. 1993;16(Suppl 3):155–165.
16.
Léonet J, Malaise J, Goffin E, et al. Solitary pancreas transplantation for life-threatening allergy to human insulin. Transpl Int. 2006;19(6):474–477.
17.
Léonet J, Malaise J, Squifflet JP. Refractory insulin allergy: pancreas transplantation or immunosuppressive therapy alone? Transpl Int. 2010;23(7):e39–40.
18.
Logtenberg SJ, Kleefstra N, Houweling ST, et al. Improved glycemic control with intraperitoneal versus subcutaneous insulin in type 1 diabetes: a randomized controlled trial. Diabetes Care. 2009;32(8):1372–1377.
19.
Cahn A, Miccoli R, Dardano A, Del Prato S. New forms of insulin and insulin therapies for the treatment of type 2 diabetes. Lancet Diabetes Endocrinol. 2015;3(8):638–652.
CrossRefPubMed